EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Advancing CRISPR technologies in reproductive biology

Shiza Hanif, Hamid Nawaz, Ali Afzal, Umair Ali Khan Saddozai, Muhammad Babar Khawar, Xinying Ji

Gene & Protein in Disease · 2024

DOI: 10.36922/gpd.2701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene & Protein in Disease, 2024. Verfasst von Shiza Hanif und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clustered regularly interspaced short palindromic repeats (CRISPR) technology, a transformative tool for genetic modifications, gene therapy, and treating various genetic diseases, has recently garnered significant attention for its applications in reproductive biology. In this realm, researchers are focusing on addressing gynecological disorders, refining assisted reproductive methods, and conducting precise germ cell editing. The potential impact of CRISPR in these areas is monumental; however, several research gaps persist, demanding further investigation into the long-term effects, safety implications, and unintended consequences of its applications in reproductive biology. Refining the precision and specificity of CRISPR technology is a critical aspect that necessitates addressing challenges such as off-target effects and cytotoxicity. These considerations underscore the urgency for ongoing research efforts to ensure the efficacy and safety of CRISPR applications. In addition, the establishment of robust regulatory frameworks and oversight mechanisms specific to CRISPR in reproductive contexts is imperative to guarantee the responsible and ethical use of this powerful technology. This comprehensive review delves into the advantages of CRISPR over traditional gene editing methods, providing insights into its applications in embryos, pluripotent stem cells, and germline cells. It further explores the risks and limitations associated with CRISPR, including ethical concerns related to designer babies and eugenics. The article sheds light on the regulatory landscape governing new CRISPR applications in reproductive biology, emphasizing the continuous improvements in the efficiency and specificity of CRISPR technology. In contributing to the ongoing discourse, this review aims to inform and guide the responsible and effective application of CRISPR in the dynamic field of reproductive biology.

Zitieren

APA

Hanif, S., Nawaz, H., Afzal, A., Saddozai, U. A. K., Khawar, M. B., & Ji, X. (2024). Advancing CRISPR technologies in reproductive biology. Gene & Protein in Disease. https://doi.org/10.36922/gpd.2701

Vancouver

Hanif S, Nawaz H, Afzal A, Saddozai UAK, Khawar MB, Ji X. Advancing CRISPR technologies in reproductive biology. Gene & Protein in Disease. 2024. doi:10.36922/gpd.2701

BibTeX
@article{Hanif2024,
  author = {Hanif, Shiza and Nawaz, Hamid and Afzal, Ali and Saddozai, Umair Ali Khan and Khawar, Muhammad Babar and Ji, Xinying},
  title = {Advancing CRISPR technologies in reproductive biology},
  journal = {Gene & Protein in Disease},
  year = {2024},
  doi = {10.36922/gpd.2701}
}
Kostenlos starten →